Laura Madukaji

ORCID: 0000-0001-9969-1929
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Pneumonia and Respiratory Infections
  • Diagnosis and treatment of tuberculosis
  • COVID-19 Pandemic Impacts
  • COVID-19 and Mental Health
  • Biosensors and Analytical Detection
  • Healthcare professionals’ stress and burnout
  • Antibiotic Use and Resistance
  • COVID-19 epidemiological studies
  • Advanced Chemical Sensor Technologies
  • Pneumocystis jirovecii pneumonia detection and treatment

Texila American University
2021

AIDS Prevention Initiative in Nigeria
2020-2021

Zankli Medical Centre
2019

Bingham University
2017-2018

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is a global pandemic. Healthcare workers' (HCWs) role in patient management predisposing and can serve as means of hospitals community transmission. This study evaluated HCWs' knowledge, attitude, practice towards COVID-19 Nigeria.we carried out cross-sectional survey among HCWs during the outbreak Nigeria from March to June 2020. The assessed 346 for Knowledge, by using an online (Google form) self-administered...

10.1016/j.heliyon.2020.e05557 article EN cc-by Heliyon 2020-11-01

Severe acute respiratory syndrome coronavirus-2 (SARS-COV-2) is the causative agent of COVID-19. This study aimed to assess preventive behavior, and responses national preparedness response readiness COVID-19 outbreak by Healthcare workers in Nigeria.A cross-sectional survey 1200 HCW was carried out, three hundred forty-six (346) responded online questionnaire on demographic characteristics, preparedness, behavior towards HCWs. Descriptive analysis variables form tables graphs out. A binary...

10.1016/j.cegh.2020.11.004 article EN cc-by-nc-nd Clinical Epidemiology and Global Health 2020-12-04

FluoroType MTB is a sensitive test for TB but specificity low compared with fully integrated molecular systems http://ow.ly/WhEO30b1luY.

10.1183/23120541.00113-2016 article EN cc-by-nc ERJ Open Research 2017-04-01

Tuberculosis (TB) incidence in Nigeria is high, with a significant burden of TB/Human Immunodeficiency Virus (HIV). Genotyping and drug susceptibility Mycobacterium tuberculosis Complex (MTBC) are important order to improve the control disease. This study sought determine genetic diversity MTBC country. The sputum samples 202 patients [133 (65.8%) males/69 (34.2%) females] were collected North Central zone cultured using Lowenstein-Jensen medium. Immunochromatography for primary...

10.2991/jegh.k.191015.001 article EN cc-by Journal of Epidemiology and Global Health 2019-01-01

Objective: Nigeria ranks fourth among the high tuberculosis (TB) burden countries. This study describes prevalence of drug resistance and genetic diversity Mycobacterium in Abuja's Federal Capital Territory. Materials methods: Two hundred seventy-eight consecutive sputum samples were collected from adults with presumptive TB during 2013–2014. DNA was extracted Löwenstein–Jensen cultures analyzed for identification nontuberculous mycobacteria species, detection line probe assays,...

10.2147/idr.s166986 article EN cc-by-nc Infection and Drug Resistance 2018-10-01

Worldwide, tuberculosis (TB) is one of the top 10 causes death. Drug resistant has lately become a major public health problem that threatens progress made in Tuberculosis care and control worldwide. The aim this study was to determine prevalence Pre-extensive drug TB among MDR North Central Nigeria.This conducted from October, 2018 August, 2019 with 150 samples. In Nigeria, guidelines for DR-TB as recommended by WHO followed. All samples patients who gave their consent were transported...

10.4314/ahs.v21i3.2 article EN African Health Sciences 2021-09-27

The efforts geared towards control of Tuberculosis is threatened by the spread multidrug resistance. Severe forms resistant TB termed Pre-extensive (Pre-XDR) and Extensively Drug (XDR) have been reported different countries including Indian, China, Russia Nigeria. Previous studies shown a strong association between these various resistance non-adherence. study was conducted to identify factors affecting adherence, assess level adherence perception care among Multidrug clients in North...

10.11648/j.ijidt.20210603.12 article EN International Journal of Infectious Diseases and Therapy 2021-01-01

Background and study aim: The use of LPA is still new in Nigeria only available TB reference laboratories.In this study, the performance version 2.0 was evaluated for detection resistant to first-line anti-TB drugs. Patients Methods:We rifampicin (RIF) isoniazid (INH) resistance.Sputum samples from 223 participants were subjected phenotypic drug susceptibility testing (PDST) LPA.Statistical analyses included calculation sensitivity, specificity, positive negative predictive values.Cross...

10.21608/aeji.2021.71788.1147 article EN cc-by Afro-Egyptian Journal of Infectious and Endemic Diseases 2021-06-23

Background: Tuberculosis (TB) has existed for millennia and ranks above HIV/AIDS as one of the top ten leading causes death worldwide from an infectious disease. Nigeria world's fourth largest tuberculosis burden drug resistance represents a public health issue. This study determines susceptibility well spoligotype distribution patterns Mycobacterium isolated in country. Methods & Materials: The sputum collected 82 patients (48 (58.5%) Males/34 (41.5%) Females) were cultured using BACTEC...

10.1016/j.ijid.2018.04.4206 article EN cc-by-nc-nd International Journal of Infectious Diseases 2018-07-27

The acquisition of MDR-TB results mainly from health system/service and patient-related factors. Previous studies showed that factors affect outcome can be human (patient, healthcare provider) system related. Poor quality care provided to TB patients affects treatment which could trigger development spread multidrug resistant TB. This study was conducted assess Multidrug clients in Drug Resistant centers North Central Nigeria also compliance provider with the standard MDR services they...

10.11648/j.wjph.20210603.12 article EN World Journal of Public Health 2021-01-01
Coming Soon ...